Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia
About this item
Full title
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2018-05, Vol.378 (19), p.1845-1848
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
More information
Scope and Contents
Contents
Anti–platelet factor 4–heparin antibodies present a major risk of heparin-induced thrombocytopenia (HIT). The use of intravenous immune globulin neutralized large amounts of these antibodies in a patient so that heparin could be used safely during emergency surgery.
Alternative Titles
Full title
Intravenous Immune Globulin to Prevent Heparin-Induced Thrombocytopenia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_29742374
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_29742374
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1801799
